Nifty 500's 2025 Gain Hides Most Stocks' Decline
While the Nifty 500 index rose 7.2% in 2025, the median stock fell 4.8%. Discover why your portfolio may have underperformed and what this means for investors.
While the Nifty 500 index rose 7.2% in 2025, the median stock fell 4.8%. Discover why your portfolio may have underperformed and what this means for investors.
Indian markets lagged in 2025 due to FII outflows & valuation concerns. Motilal Oswal sees a 2026 rebound on strong earnings. Get 5 expert stock picks for long-term.
2025 set a record with ₹1.75 lakh crore raised via IPOs, but nearly half the stocks sank below issue price. Experts reveal the clash between hype and fundamentals shaping India's primary market. Learn what this means for 2026 investors.
Nifty 50 extends bull run for 10th year, but 26 blue-chip stocks like Shriram Finance, Maruti Suzuki soared 11-72%, outperforming the index. Discover the sectors and stocks that led the charge and the 2026 outlook.
Indian primary market hit a record high in 2025 with 103 IPOs raising ₹1.75 lakh crore. However, six of the ten most-demanded IPOs failed to sustain listing gains, signaling a shift for investors. Read the full analysis.
India's record-breaking IPO year ends with a sobering truth: nearly 50% of 2025's new listings now trade below their issue price. Discover the winners, losers, and what this means for investors in 2026.
India's record 2025 IPO boom faces a reality check. While Rs 1.75 lakh crore was raised, 47 stocks now trade below issue price. Experts urge focus on fundamentals over hype. Read the full analysis.
Retail investors chasing quick gains face reality as 35 of 107 IPOs in 2025 trade at a loss. Key factors like high valuation and weak sentiment impact performance. Learn which IPOs bled the most on debut.
Indian stock market lags behind global peers in 2025, with Pakistan and South Korea delivering stellar returns. Discover the reasons behind FII outflows and the outlook for a rebound.
KSH International's IPO debuts on stock exchanges today. Check the latest GMP, listing price, and key details for investors. Stay informed on this market move.
KSH International's IPO lists on BSE & NSE on December 23, 2025. Experts predict a muted debut amid tepid investor response and a grey market discount. Read analysis.
Austere Systems' IPO, the most-subscribed in 2025, saw a dramatic fall after listing. Discover the risks behind SME IPOs and why retail investors are losing money. Read before you invest.
ICICI Prudential AMC debuted on stock exchanges with a strong 20% premium. While profit booking caused a dip, analysts see this as a long-term portfolio stock for steady wealth creation. Read expert views.
ICICI Prudential Asset Management Company made a strong stock market debut with a 20% premium. The IPO was subscribed 39 times. Analysts recommend long-term holding. Read more.
ICICI Prudential AMC IPO lists on NSE, BSE Friday. Grey market premium at ₹454 hints at strong debut. Issue was oversubscribed 39 times. Read details.
Park Medi World Ltd's shares list on BSE & NSE today. Check the listing price, grey market premium (GMP), subscription data, and expert views for the healthcare IPO.
Despite a volatile 2025, India's IPO market thrived with 81 listings raising ₹1.21 lakh crore. Discover the trends, top gainers, and why 47% of new stocks are trading below issue price. Read now for key insights.
SSMD Agrotech shares made a weak market debut, listing at a 39.67% discount. Discover the IPO details, subscription figures, and the company's future plans for the raised capital.
Supreme Court streamlines case listing with automatic listing system & 2-day hearings for liberty matters. New guidelines effective December 1 aim to reduce pendency. Read more.
November 2025 witnessed 9 IPOs with 12 listings. Groww leads with 58.85% gains while experts warn of investor fatigue and unrealistic valuations. Read full analysis.
Sudeep Pharma shares surged 33.78% in market debut, exceeding expectations. Analysts advise partial profit booking while maintaining long-term optimism. Read expert views on buy/sell strategy.
Sudeep Pharma makes its stock market debut today. With a GMP of ₹121, the IPO is set for 20% listing gains after a blockbuster 93.72 times subscription. Get all the live details.
Sudeep Pharma shares list on BSE and NSE today after 93.72 times subscription. Grey market signals 20% premium debut. Full details on pricing and investor response.
Sudeep Pharma IPO makes Dalal Street debut on November 28. Grey market premium hits ₹100, signaling 15% listing gain. Discover subscription details and key facts.
Indian stock markets surge as Nifty 50 reaches historic peak after 14-month wait. Sensex climbs over 200 points amid strong global cues and domestic buying. Discover what's driving this rally.
Excelsoft Technologies shares fell over 5% after making a strong debut with 12.5% premium. Analyst recommends partial profit booking with stop-loss at ₹130. Read full analysis.
Excelsoft Technologies made a stellar market debut with 12.5% premium listing after IPO oversubscribed 45 times. The company raised Rs 500 crore through public offer. Read full analysis.
Excelsoft Technologies makes stock market debut today after successful IPO. Check listing price, GMP trends, and key financial details for investors.
Excelsoft Technologies makes stock market debut today at ₹127 per share, 5.83% above IPO price. The company's shares began trading at 10:00 IST in special pre-open session.
Excelsoft Technologies shares list today after 43x oversubscribed IPO. GMP signals modest 6% premium. Get complete listing details, price band analysis & market expectations.